异环磷酰胺/美司钠静脉输注与华法林抗凝控制的干扰
Intravenous infusions of ifosfamide/mesna and perturbation of warfarin anticoagulant control.
作者信息
Hall G, Lind M J, Huang M, Moore A, Gane A, Roberts J T, Cantwell B M
机构信息
University Department of Clinical Oncology, Newcastle General Hospital, Newcastle upon Tyne, UK.
出版信息
Postgrad Med J. 1990 Oct;66(780):860-1. doi: 10.1136/pgmj.66.780.860.
Abstract
We report three patients who had serious disturbance of anticoagulant control while receiving ifosfamide/mesna-containing cytotoxic chemotherapy in association with warfarin. In view of the likely biological potentiation of warfarin by ifosfamide/mesna, close monitoring of anticoagulant control should be performed during the co-administration of these drugs.
摘要
我们报告了三名患者，他们在接受含异环磷酰胺/美司钠的细胞毒性化疗联合华法林治疗期间，抗凝控制出现严重紊乱。鉴于异环磷酰胺/美司钠可能对华法林产生生物学增效作用，在联合使用这些药物期间应密切监测抗凝控制情况。
相似文献
1
Intravenous infusions of ifosfamide/mesna and perturbation of warfarin anticoagulant control.异环磷酰胺/美司钠静脉输注与华法林抗凝控制的干扰
Postgrad Med J. 1990 Oct;66(780):860-1. doi: 10.1136/pgmj.66.780.860.
2
Ifosfamide/mesna encephalopathy.异环磷酰胺/美司钠脑病
Lancet. 1987 Apr 25;1(8539):987. doi: 10.1016/s0140-6736(87)90343-6.
3
Dosing and side-effects of ifosfamide plus mesna.异环磷酰胺加美司钠的剂量及副作用
J Cancer Res Clin Oncol. 1991;117 Suppl 4(Suppl 4):S164-86. doi: 10.1007/BF01613224.
4
Irreversible encephalopathy with ifosfamide/mesna.异环磷酰胺/美司钠所致不可逆性脑病
J Clin Oncol. 1987 Aug;5(8):1303-4. doi: 10.1200/JCO.1987.5.8.1303.
5
Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer.毒性及对大剂量异环磷酰胺+美司钠作为晚期乳腺癌挽救治疗的反应
J Cancer Res Clin Oncol. 1988;114(6):602-4. doi: 10.1007/BF00398184.
6
Encephalopathy with rapid infusion ifosfamide/mesna.快速输注异环磷酰胺/美司钠所致脑病
Lancet. 1987 Feb 14;1(8529):390-1. doi: 10.1016/s0140-6736(87)91769-7.
7
Continuously improving ifosfamide/mesna: a winning combination.不断改进的异环磷酰胺/美司钠：成功组合
Pediatr Blood Cancer. 2010 Oct;55(4):599-600. doi: 10.1002/pbc.22652.
8
Severe renal failure following high-dose ifosfamide and mesna.大剂量异环磷酰胺和美司钠治疗后出现的严重肾衰竭。
Cancer Chemother Pharmacol. 1989;23(5):329-30. doi: 10.1007/BF00292414.
9
CNS-side effects induced by Ifosfamide-Mesna in children with osteosarcomas.异环磷酰胺-美司钠对骨肉瘤患儿中枢神经系统的副作用
Biomed Pharmacother. 1986;40(5):173-5.
10
Ifosfamide/mesna and hematuria.异环磷酰胺/美司钠与血尿
Cancer Treat Rep. 1987 Nov;71(11):1124-5.
引用本文的文献
1
Effect of gefitinib on warfarin antithrombotic activity.吉非替尼对华法林抗血栓活性的影响。
Int J Clin Oncol. 2009 Aug;14(4):332-6. doi: 10.1007/s10147-008-0871-2. Epub 2009 Aug 25.
2
Clinically important drug interactions with anticoagulants. An update.与抗凝剂相关的具有临床重要意义的药物相互作用。最新进展。
Clin Pharmacokinet. 1996 Jun;30(6):416-44. doi: 10.2165/00003088-199630060-00002.
3
Clinically significant drug interactions with the oral anticoagulants.与口服抗凝剂具有临床意义的药物相互作用。
Drug Saf. 1994 May;10(5):381-94. doi: 10.2165/00002018-199410050-00003.
4
Antineoplastic agents. Drug interactions of clinical significance.抗肿瘤药。具有临床意义的药物相互作用。
Drug Saf. 1995 Mar;12(3):168-82. doi: 10.2165/00002018-199512030-00003.
本文引用的文献
1
The effect of cytotoxic agents on drug metabolism.
Eur J Cancer (1965). 1970 Apr;6(2):125-6. doi: 10.1016/0014-2964(70)90009-5.
2
Thromboses and thromboemboli in patients with lymphoma during cytotoxic chemotherapy.淋巴瘤患者在细胞毒性化疗期间的血栓形成和血栓栓塞
BMJ. 1988 Jul 16;297(6642):179-80. doi: 10.1136/bmj.297.6642.179.
3
Ifosfamide.
J Natl Cancer Inst. 1988 Jun 15;80(8):556-66. doi: 10.1093/jnci/80.8.556.
4
5
Thromboembolic events during combination chemotherapy for germ cell-malignancy.生殖细胞恶性肿瘤联合化疗期间的血栓栓塞事件。
Lancet. 1988 Nov 5;2(8619):1086-7. doi: 10.1016/s0140-6736(88)90113-4.
6
Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.采用气相色谱-化学电离质谱法对接受环磷酰胺治疗的患者血浆和尿液中环磷酰胺、磷酰胺氮芥和去甲氮芥进行定量分析。
Cancer Res. 1978 Feb;38(2):408-15.
Zotero 插件